NEW ORLEANS — A monoclonal antibody targeting interferon beta (IFN-beta) provided substantial reductions in the skin lesions associated with dermatomyositis in a double-blind, placebo-controlled phase ...

Dermatomyositis (DM) is a chronic autoimmune disease characterized by inflammatory myopathy and distinctive skin manifestations, significantly affecting patients' quality of life. Dazukibart, a novel ...

—These investigators explored how knowing the distinctive features of dermatomyositis in Black adults, which may be subtle, could possibly lead to faster and more accurate diagnosis. Dermatomyositis ...

Juvenile dermatomyositis, a rare but often severe and chronic systemic autoimmune disease, includes a large number of patients who are treatment resistant, requiring long term immunosuppressive ...

Classic DM (CDM) presents with pathognomonic cutaneous findings and progressive, symmetric proximal muscle weakness. Cutaneous disease usually precedes the appearance of myositis by 3–6 months in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The phase 3 study will evaluate brepocitinib’s efficacy ...

ALPHARETTA, Ga. - At just 4-years-old, Mila Sherry loves reading picture books with her mom, Anna Sherry. But, for the past year, the Alpharetta preschooler has been living a story of her own, a kind ...

Intermittent intravenous methylprednisolone pulse (IVMP) and mycophenolate mofetil (MMF) led to a complete clinical response in 93% of patients with juvenile dermatomyositis (JDM), with manageable ...